Impact Investing
This function is exclusive for Premium subscribers
-
DATABASE (17)
-
ARTICLES (26)
Crevisse Partners is a South Korean investor and venture builder with an impact focus. Its name stands for “Creative, Visionary and Social Entrepreneurs”. Originally incorporated in 2004, Crevisse claims to be the first impact investor in Korea, even before such terms became commonplace. The company strives to develop businesses in sectors “where the market principle wasn’t working”.Crevisse has internally incubated a number of companies in South Korea, such as reusable drinking cup company BringYourCup, sustainable forestry firm Forest Trust, and fundraising service DONUS. Crevisse Ventures is the company’s dedicated VC arm that manages a $20m fund and a number of blended finance funds through collaborations with government agencies and financial institutions. In particular, Crevisse Ventures focuses on startups that solve problems in four major areas: urban communities; climate and energy; education and welfare; as well as jobs and economic growth.
Crevisse Partners is a South Korean investor and venture builder with an impact focus. Its name stands for “Creative, Visionary and Social Entrepreneurs”. Originally incorporated in 2004, Crevisse claims to be the first impact investor in Korea, even before such terms became commonplace. The company strives to develop businesses in sectors “where the market principle wasn’t working”.Crevisse has internally incubated a number of companies in South Korea, such as reusable drinking cup company BringYourCup, sustainable forestry firm Forest Trust, and fundraising service DONUS. Crevisse Ventures is the company’s dedicated VC arm that manages a $20m fund and a number of blended finance funds through collaborations with government agencies and financial institutions. In particular, Crevisse Ventures focuses on startups that solve problems in four major areas: urban communities; climate and energy; education and welfare; as well as jobs and economic growth.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
- 1
- 2
Southeast Asian startups to keep riding digitalization, IPO boom, investors say
O2O business models and growing interest in ESG are also key themes, as regional startups gain $4.4bn of funding in first half of 2021
South Summit wants to go global, as it launches Brazilian chapter
CEO Marta del Castillo on South Summit’s LatAm, Asia expansion plans; its net-zero pledge; her new role as co-head to further drive growth and more
Indonesian angel investor network ANGIN launches agrifood incubator
Program targets ESG investment and builds on the strong potential of Indonesia’s agriculture sector, which kept growing despite the Covid-19 pandemic
Smart Agrifood 2021: SVG Ventures's Hartnett, Land O'Lakes's Bekele on disruption in agrifood chain
How US farming cooperative Land O'Lakes and leading CPG brands are working with famers and tech firms to overcome agritech challenges, transform the whole value chain
Good Startup: Alt-protein products can be better than real meat
The investor of Eat Just, Ripple Foods and more expects its portfolio companies will exit in the next four to six years, mostly through acquisition
MioTech: Early mover in China ESG data and analytics for investing, corporate reporting
Hong Kong-based fintech uses AI technologies to monitor ESG data and risks in real time, turn unstructured data into reliable insights
Accelerating Asia bets on unicorn wave from MSME digitalization, logistics
The investor-accelerator’s sixth batch will start accepting applications in December, with greater ESG focus and a pledge to donate 1% of profit on investments to charity
Taronga Ventures takes RealTechX to Singapore; plans Japan, US growth
The Australian proptech investor to focus on ESG in its acceleration program, including women under-representation and site safety
Dao Foods unfazed by China tech crackdown, says alternative proteins aligned with state goals
Impact investor Dao Foods expects government support for alternative proteins to come, as it announces second batch of startups, diversifying into fermentation and cell-based proteins
Future Food Asia 2021: Regenerative agriculture in Asia
The unique challenges facing regenerative agriculture in Asia require solutions different from those in the West, presenting opportunities for microfinancing and impact investment
Future Food Asia 2021: Two winners take home $100,000 each
Agrifood startups, corporations and investors urged to collaborate and take action, tackling challenges in nutrition and climate change
Future Food Asia 2021: Impact assessments – getting the metrics right
Common impact measures are useful but each situation requires specific, sometimes subjective considerations. The priority is to gauge if the impact has led to positive changes
Future Food Asia 2021: Consumers crucial for agrifood growth
President of AppHarvest David Lee thinks consumers must be told the truth about the need for technology for change in food because capitalism and consumerism are powerful forces
AgroCenta: Providing market access and credit to African smallholder farmers
AgroCenta’s platforms empower Ghanaian subsistence farmers, especially women, boosting productivity and sales with e-payments, micro-credits and insurance, and direct connections to buyers, cutting out the intermediaries
Biomilq: Creating cell-based mothers’ milk in a lab
With the aim of helping women struggling to breastfeed, Bill Gates-backed Biomilq is disrupting the $45bn baby formula industry developing lab-grown breast milk from mammary epithelial cells
- 1
- 2
POPULAR DATABASE
